文献速递鼻科

中央区变应性疾病与外侧为主型鼻息肉的比较

A comparison of central compartment atopic disease and lateral dominant nasal polyps.
PubMed 文献 · Int Forum Allergy Rhinol · 2022-04-11

本研究为台湾某三级医院的病例对照研究,纳入442例接受功能性内镜鼻窦手术的慢性鼻窦炎伴鼻息肉患者,分为中央区变应性疾病(CCAD)组51例和外侧为主型鼻息肉(LDNP)组391例。CCAD与哮喘及变应性鼻炎症状相关,血清及组织嗜酸性粒细胞更高,术后SNOT-22和黏液纤毛清除时间改善更明显,修正性FESS率无差异。

要点

  • CCAD与哮喘(9.8% vs 3.5%)和变应性鼻炎症状(43.3% vs 26.6%)相关。
  • CCAD组血清嗜酸性粒细胞(5.8% vs 2.8%)和组织嗜酸性粒细胞(57.0 vs 17.3)更高。
  • CCAD组FESS术后SNOT-22和MCT改善优于LDNP组,修正性FESS率无差异。

核心结论

  • 在台湾患者中,起源于中央区的鼻息肉与哮喘和变应性鼻炎相关,CCAD患者血清和局部鼻组织嗜酸性粒细胞计数更高,FESS可有效缓解CCAD症状。

研究设计与样本

  • 病例对照研究,纳入台湾某三级医院接受功能性内镜鼻窦手术的慢性鼻窦炎伴鼻息肉患者442例,根据内镜和CT影像分为CCAD组51例和LDNP组391例。

主要发现

  • CCAD组哮喘比例为9.8%,LDNP组为3.5%(p=0.04)。
  • CCAD组变应性鼻炎症状比例为43.3%,LDNP组为26.6%(p=0.01)。
  • CCAD组血清嗜酸性粒细胞为5.8%,LDNP组为2.8%(p<0.01)。
  • CCAD组组织嗜酸性粒细胞为57.0,LDNP组为17.3(p<0.01)。
  • CCAD组SNOT-22评分改善-31.82,LDNP组改善-22.66(p<0.01);CCAD组MCT改善-233.06秒,LDNP组改善-191.93秒(p=0.03)。

临床怎么用

  • 原文结论指出FESS是缓解CCAD患者症状的有效治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The characteristics and surgical outcomes of central compartment atopic disease (CCAD) vary by region and race. Therefore, we aimed to identify the risk factors, symptom severity, and prognosis of CCAD in the Asian population. METHODS: This case-control study recruited patients diagnosed with chronic rhinosinusitis with nasal polyps who underwent functional endoscopic sinus surgery (FESS) at a tertiary hospital in Taiwan. Patients were classified into CCAD and lateral-dominant nasal polyp (LDNP) groups based on endoscopic and computed tomography imaging findings. The demographic data, symptom severity scores, and surgical outcomes of the 2 groups were analyzed. RESULTS: Our study included 442 patients (CCAD group: n = 51; LDNP group: n = 391). We found that CCAD was strongly related to both asthma (9.8% vs 3.5%, p = 0.04) and allergic rhinitis symptoms (43.3% vs 26.6%, p = 0.01). Higher eosinophil counts were detected in blood serum (5.8% vs 2.8%, p < 0.01) and histopathologic profiles (57.0 vs 17.3, p < 0.01) among patients with CCAD. Improvements in 22-item Sino-Nasal Outcome Test (SNOT-22) score and mucociliary clearance time (MCT) after surgical intervention revealed that the CCAD group had a better response to FESS (SNOT-22 score: -31.82 vs -22.66, p < 0.01; MCT: -233.06 vs -191.93 seconds, p = 0.03). The revision FESS rate was not different between the 2 groups. CONCLUSION: Polyps originating from the central compartment were found to be related to asthma and allergic rhinitis in Taiwanese patients. A higher eosinophil count was suggested in both serum and local nasal tissue from patients with CCAD. FESS serves as an effective treatment for symptom relief in patients with CCAD.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Shih LC, Hsieh BH, Ma JH, et al. A comparison of central compartment atopic disease and lateral dominant nasal polyps. Int Forum Allergy Rhinol. 2022. PMID: 35347864. doi:10.1002/alr.22996

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。